Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 66Carcinoma, Non-Small-Cell Lung 39Breast Neoplasms 32Triple Negative Breast Neoplasms 25Neoplasm Metastasis 18Neoplasms 15Lung Neoplasms 15Colorectal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 6Ovarian Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Head and Neck Neoplasms 5Gallbladder Neoplasms 5Fallopian Tube Neoplasms 5Esophageal Squamous Cell Carcinoma 5Adenocarcinoma 5Esophageal Neoplasms 4Cholangiocarcinoma 4Carcinoma, Pancreatic Ductal 4Carcinoma 4Neoplasms by Site 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Brain Neoplasms 3Biliary Tract Neoplasms 3Vaccinia 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Small Cell Lung Carcinoma 2

Interventions

Mitozytrex 1Mitomycin 1Iodized Oil 1Ethiodized Oil 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mediastinal Neoplasms × 130-nm albumin-bound paclitaxel × 1 year × Clear all
NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2/3 Not yet recruiting
116 enrolled
Thoracic

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡